首頁 › 心血管疾病 › 明尼蘇達 › Minneapolis
Minneapolis, MN 的 心血管疾病 臨床試驗
15 項針對 心血管疾病 的研究正在 Minneapolis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
ELEVATE-HFpEF Clinical Study
招募中
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
招募中
- Minneapolis Heart Institute, Minneapolis
Product Surveillance Registry
招募中觀察性研究
- Minneapolis, Minneapolis
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
招募中
- Abbott Northwestern Hospital, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
招募中觀察性研究
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
招募中3 期
- Research Site, Minneapolis
- Research Site, Minneapolis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
招募中3 期
- University of Minnesota, Minneapolis
- Methodist Hospital, Saint Louis Park · 距離 5 英里
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
招募中
- Minneapolis Heart Institute Foundation, Minneapolis
The TRICURE EFS Study
招募中
- Minneapolis Heart Institute Foundation, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
招募中
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- Minneapolis Heart Institute, Minneapolis
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
招募中3 期
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
招募中早期第 1 期
- University of Minnesota, Minneapolis
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
招募中
- Minneapolis Heart Institute Foundation, Minneapolis
其他城市的 心血管疾病 試驗
- Boston, MA37 項研究
- New York City, NY33 項研究
- Washington, DC28 項研究
- Houston, TX24 項研究
- Dallas, TX23 項研究
- Atlanta, GA22 項研究
- Cleveland, OH22 項研究
- Chicago, IL21 項研究
- Philadelphia, PA21 項研究
- Pittsburgh, PA20 項研究
- St. Louis, MO20 項研究
- Nashville, TN18 項研究
Minneapolis 的其他研究
- 非小細胞肺癌27 項研究
- 乳癌27 項研究
- 卵巢癌24 項研究
- 前列腺癌23 項研究
- 癌症（所有類型）22 項研究
- 心臟衰竭21 項研究
- 急性髓系白血病20 項研究
- 肺癌20 項研究
- 大腸直腸癌19 項研究
- 子宮內膜癌18 項研究
- 帕金森氏症17 項研究
- 冠狀動脈疾病13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。